No Data
No Data
Unusual Options Activity: STX, MSFT and Others Attract Market Bets, STX V/OI Ratio Reaches 166.7
Guardant Health's Strategic Growth: Shield's Coverage Expansion and Revenue Potential
Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating
Guardant Health Price Target Maintained With a $55.00/Share by Stephens & Co.
Guardant Health Analyst Ratings
Guardant Health's Shield Blood Test Now Covered for VA Community Care Beneficiaries